TaiMed Biologics (Taiwan) Price on December 13, 2024
| 4147 Stock | TWD 83.00 2.10 2.47% |
If you're considering investing in TaiMed Stock, it is important to understand the factors that can impact its price. As of today, the current price of TaiMed Biologics stands at 83.00, as last reported on the 14th of December 2024, with the highest price reaching 85.40 and the lowest price hitting 82.30 during the day. At this stage we consider TaiMed Stock to be very steady. TaiMed Biologics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0465, which indicates the firm had a 0.0465% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for TaiMed Biologics, which you can use to evaluate the volatility of the company. Please validate TaiMed Biologics' Risk Adjusted Performance of 0.0315, semi deviation of 1.3, and Coefficient Of Variation of 2849.54 to confirm if the risk estimate we provide is consistent with the expected return of 0.0875%.
TaiMed Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
TaiMed |
Sharpe Ratio = 0.0465
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | 4147 | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.88 actual daily | 16 84% of assets are more volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average TaiMed Biologics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TaiMed Biologics by adding it to a well-diversified portfolio.
TaiMed Biologics Valuation on December 13, 2024
It is possible to determine the worth of TaiMed Biologics on a given historical date. On December 13, 2024 TaiMed was worth 85.4 at the beginning of the trading date compared to the closed value of 83.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of TaiMed Biologics stock. Still, in general, we apply an absolute valuation method to find TaiMed Biologics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of TaiMed Biologics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against TaiMed Biologics' related companies.
| Open | High | Low | Close | Volume | |
| 86.70 | 87.60 | 84.50 | 85.10 | 501,183 | |
12/13/2024 | 85.40 | 85.40 | 82.30 | 83.00 | 472,942 |
| Backtest TaiMed Biologics | | | TaiMed Biologics History | | | TaiMed Biologics Valuation | Previous |
TaiMed Biologics Trading Date Momentum on December 13, 2024
| On December 13 2024 TaiMed Biologics was traded for 83.00 at the closing time. The highest price during the trading period was 85.40 and the lowest recorded bid was listed for 82.30 . The volume for the day was 472.9 K. This history from December 13, 2024 did not result in any price rise and fall. The trading price change to the current price is 2.89% . |
TaiMed Biologics Fundamentals Correlations and Trends
By evaluating TaiMed Biologics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among TaiMed Biologics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. TaiMed financial account trend analysis is a perfect complement when working with valuation or volatility modules.About TaiMed Biologics Stock history
TaiMed Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for TaiMed is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in TaiMed Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing TaiMed Biologics stock prices may prove useful in developing a viable investing in TaiMed Biologics
TaiMed Biologics Inc., a biotechnology company, develops health-care products. The company was founded in 2007 and is based in Taipei City, Taiwan. TAIMED BIOLOGICS operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.
TaiMed Biologics Stock Technical Analysis
TaiMed Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
TaiMed Biologics Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
TaiMed Biologics cannot be verified against its exchange. Please verify the symbol is currently traded on Taiwan OTC Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
TaiMed Biologics December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how TaiMed Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading TaiMed Biologics shares will generate the highest return on investment. By undertsting and applying TaiMed Biologics stock market strength indicators, traders can identify TaiMed Biologics entry and exit signals to maximize returns
TaiMed Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for TaiMed Biologics' price direction in advance. Along with the technical and fundamental analysis of TaiMed Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of TaiMed to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0315 | |||
| Jensen Alpha | 0.0623 | |||
| Total Risk Alpha | (0.17) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | (0.64) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for TaiMed Stock Analysis
When running TaiMed Biologics' price analysis, check to measure TaiMed Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TaiMed Biologics is operating at the current time. Most of TaiMed Biologics' value examination focuses on studying past and present price action to predict the probability of TaiMed Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TaiMed Biologics' price. Additionally, you may evaluate how the addition of TaiMed Biologics to your portfolios can decrease your overall portfolio volatility.